1.
J Virol Methods
; 299: 114337, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34687785
RESUMO
In Emergency Room, Point-of-care antigen testing for SARS-CoV-2 antigen can expedite clinical strategies for patient management. We tested 1,232 consecutive patients during Italian second wave peak using the recent LumiraDx microfluidic assay. This assay showed high concordance (96.9 %), sensitivity and specificity compared to molecular testing, being highly valuable.